News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Horton Kenneth L
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2023 |
4
| Horton Kenneth L (GC & Corp. Development Advisor) has filed a Form 4 on Senseonics Holdings, Inc.|
Txns:
| Paid exercise price by delivering 26,105 shares
@ $0.97, valued at
$25.3k
Paid exercise price by delivering 104,306 shares
@ $1.25, valued at
$130.4k
Paid exercise price by delivering 137,927 shares
@ $0.74, valued at
$102.1k
Granted 782,089 shares
@ $0 |
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Horton Kenneth L (GC & Corp. Development Advisor) has filed a Form 4 on Senseonics Holdings, Inc.|
Txns:
| Paid exercise price by delivering 45,430 shares
@ $1.13, valued at
$51.3k
|
|
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| Horton Kenneth L (GC & Corp. Development Advisor) has filed a Form 4 on Senseonics Holdings, Inc.|
Txns:
| Paid exercise price by delivering 46,426 shares
@ $3.8, valued at
$176.4k
|
|
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
3
| Horton Kenneth L (GC & Corp. Development Advisor) has filed a Form 3 on Senseonics Holdings, Inc. |
| 11/19/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2014 |
4
| Horton Kenneth L (EVP & Chief Legal Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 40,000 shares
@ $0.01, valued at
$400 |
|
| 10/01/2014 |
4
| Horton Kenneth L (EVP & Chief Legal Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 4,713 shares
@ $111.33, valued at
$524.7k
Sold 14,286 shares
@ $112.22, valued at
$1.6M
Sold 9,601 shares
@ $113.1, valued at
$1.1M
Sold 7,400 shares
@ $113.91, valued at
$842.9k
Exercised 36,000 options to buy
@ $55.83, valued at
$2M
|
|
| 07/17/2014 |
4
| Horton Kenneth L (EVP & Chief Legal Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 34,000 options to buy
@ $96.87, valued at
$3.3M
|
|
| 07/03/2014 |
4
| Horton Kenneth L (EVP & Chief Legal Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2,257 shares
@ $94.49, valued at
$213.3k
Sold 27,877 shares
@ $95.28, valued at
$2.7M
Exercised 28,321 options to buy
@ $45.11, valued at
$1.3M
|
|
| 02/07/2014 |
4
| Horton Kenneth L (EVP & Chief Legal Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 17,250 shares
@ $0.01, valued at
$172.5
Granted 51,000 options to buy
@ $77.31, valued at
$3.9M
|
|
| 12/12/2013 |
4
| Horton Kenneth L (EVP & Chief Legal Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 4,532 shares
@ $65.46, valued at
$296.7k
|
|
| 08/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/13/2012 |
4
| Horton Kenneth L (EVP & Chief Legal Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 9,667 shares
@ $0.01, valued at
$96.7
Granted 72,000 options to buy
@ $55.83, valued at
$4M
|
|
| 06/13/2012 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|